Application of Meta Learning to B-Cell Conformational Epitope Prediction

Author(s):  
Yuh-Jyh Hu
2014 ◽  
Vol 15 (1) ◽  
Author(s):  
Yuh-Jyh Hu ◽  
Shun-Chien Lin ◽  
Yu-Lung Lin ◽  
Kuan-Hui Lin ◽  
Shun-Ning You

2020 ◽  
Vol 6 ◽  
pp. e275
Author(s):  
Binti Solihah ◽  
Azhari Azhari ◽  
Aina Musdholifah

Background A conformational B-cell epitope is one of the main components of vaccine design. It contains separate segments in its sequence, which are spatially close in the antigen chain. The availability of Ag-Ab complex data on the Protein Data Bank allows for the development predictive methods. Several epitope prediction models also have been developed, including learning-based methods. However, the performance of the model is still not optimum. The main problem in learning-based prediction models is class imbalance. Methods This study proposes CluSMOTE, which is a combination of a cluster-based undersampling method and Synthetic Minority Oversampling Technique. The approach is used to generate other sample data to ensure that the dataset of the conformational epitope is balanced. The Hierarchical DBSCAN algorithm is performed to identify the cluster in the majority class. Some of the randomly selected data is taken from each cluster, considering the oversampling degree, and combined with the minority class data. The balance data is utilized as the training dataset to develop a conformational epitope prediction. Furthermore, two binary classification methods, Support Vector Machine and Decision Tree, are separately used to develop model prediction and to evaluate the performance of CluSMOTE in predicting conformational B-cell epitope. The experiment is focused on determining the best parameter for optimal CluSMOTE. Two independent datasets are used to compare the proposed prediction model with state of the art methods. The first and the second datasets represent the general protein and the glycoprotein antigens respectively. Result The experimental result shows that CluSMOTE Decision Tree outperformed the Support Vector Machine in terms of AUC and Gmean as performance measurements. The mean AUC of CluSMOTE Decision Tree in the Kringelum and the SEPPA 3 test sets are 0.83 and 0.766, respectively. This shows that CluSMOTE Decision Tree is better than other methods in the general protein antigen, though comparable with SEPPA 3 in the glycoprotein antigen.


2021 ◽  
Vol 9 (1) ◽  
pp. 131
Author(s):  
Binti Solihah ◽  
Azhari Azhari ◽  
Aina Musdholifah

A conformational epitope is a part of a protein-based vaccine. It is challenging to identify using an experiment. A computational model is developed to support identification. However, the imbalance class is one of the constraints to achieving optimal performance on the conformational epitope B cell prediction. In this paper, we compare several conformational epitope B cell prediction models from non-ensemble and ensemble approaches. A sampling method from Random undersampling, SMOTE, and cluster-based undersampling is combined with a decision tree or SVM to build a non-ensemble model. A random forest model and several variants of the bagging method is used to construct the ensemble model. A 10-fold cross-validation method is used to validate the model.  The experiment results show that the combination of the cluster-based under-sampling and decision tree outperformed the other sampling method when combined with the non-ensemble and the ensemble method. This study provides a baseline to improve existing models for dealing with the class imbalance in the conformational epitope prediction.


2009 ◽  
Vol 12 (9) ◽  
pp. 31-37
Author(s):  
Vinh Ngoc Tran ◽  
Quy Cam Vo ◽  
Thuoc Linh Tran

Although discontinuous epitopes make up 90% of total number of B-cell epitopes, however, because of difficulties in the development of method for their prediction, most of the B-cell epitope prediction methods today focus on continuous epitopes. To serve for the development of vaccine against H5N1 virus, we have been studying on in silico prediction of T- and B-cell continuous as well as B-cell discontinuous epitopes on H5N1 viral antigens. In this study, using the homology modeling method, we have generated structures of matrix protein of the H5N1 virus and predicted B-cell discontinuous epitopes. 60 out of 72 predicted residues were similar with those reported by the CEP method (Conformational Epitope Prediction). All predicted aminoacid residues were hydrophilic, polar, electrically charged and located on the surface of the antigen structures.


2019 ◽  
Vol 19 (1) ◽  
pp. 36-45 ◽  
Author(s):  
Marzieh Rezaei ◽  
Mohammad Rabbani-khorasgani ◽  
Sayyed Hamid Zarkesh-Esfahani ◽  
Rahman Emamzadeh ◽  
Hamid Abtahi

Background:Brucellosis is an infectious disease caused by Brucella bacteria that cause disease in animals and humans. Brucellosis is one of the most common zoonotic diseases transmitted from animals-to-human through direct contact with infected animals and also consumption of unpasteurized dairy products. Due to the wide incidence of brucellosis in Iran and economical costs in industrial animal husbandry, Vaccination is the best way to prevent this disease. All of the available commercial vaccines against brucellosis are derived from live attenuated strains of Brucella but because of the disadvantage of live attenuated vaccines, protective subunit vaccine against Brucella may be a good candidate for the production of new recombinant vaccines based on Brucella Outer Membrane Protein (OMP) antigens. In the present study, comprehensive bioinformatics analysis has been conducted on prediction software to predict T and B cell epitopes, the secondary and tertiary structures and antigenicity of Omp16 antigen and the validation of used software confirmed by experimental results.Conclusion:The final epitope prediction results have proposed that the three epitopes were predicted for the Omp16 protein with antigenicity ability. We hypothesized that these epitopes likely have the protective capacity to stimulate both the B-cell and T-cell mediated immune responses and so may be effective as an immunogenic candidate for the development of an epitope-based vaccine against brucellosis.


Sign in / Sign up

Export Citation Format

Share Document